WCN26-7696 EFFICACY AND SAFETY OF NALFURAFINE FOR REFRACTORY PRURITUS IN HEMODIALYSIS PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Read full text Summarise with VIRAT
Authors: Hendra Perkasa, Pringgodigdo Nugroho, Maruhum Bonar Hasiholan Marbun, Muhammad Irvan Almaqdisi, Jason Phowira, Ni Made Hustrini
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Uremic pruritus, a prevalent and debilitating symptom in patients with chronic kidney disease receiving dialysis, significantly impairs quality of life and remains challenging to manage. Limited data available on the benefit and safety of nalfurafine, a selective kappa-opioid receptor agonist, in this population. Our systematic review and meta-analysis aims to evaluate the efficacy and safety of nalfurafine versus placebo for refractory pruritus in hemodialysis patients.

Fields of Study & Subjects

Dialysis and Renal Disease Management Dermatology and Skin Diseases Parathyroid Disorders and Treatments

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105323–105323
Publication date
25 March 2026
Language
EN